Seminars in Diagnostic Pathology
Volume 24, Issue 1 , Pages 43-47 , February 2007

Clinical syndromes with variable pathologic features

  • Frederick T. Kraus, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Frederick T. Kraus, MD, Washington University Medical School, Department of OB-GYN, Campus Box 8064, St. Louis, MO 63110.

References 

  1. In:  Hankins GDV editors. Neonatal Encephalopathy and Cerebral Palsy. Washington DC: American College of Obstetricians and Gynecologists; 2003;
  2. Badawi N, Felix JF, Kurinczuk JJ, et al. Cerebral palsy following term newboborn encephalopathy. Dev Med Child Neurol. 2005;47:293–298
  3. McDonald DG, Kelehan P, McMenamin JB, et al. Placental fetal thrombotic vasculopathy is associated with neonatal encephalopathy. Hum Pathol. 2004;35:875–880
  4. Redline RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol. 2004;35:1494–1498
  5. Redline R, O’Riordan MA. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Arch Pathol Lab Med. 2000;124:1785–1791
  6. Redline RW, Wilson-Costello D, Borawski E, et al. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth weight infants. Arch Pathol Lab Med. 1998;122:1091–1098
  7. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452–457
  8. Redline RW. Placental pathology and cerebral palsy. Clin Perinatal. 2006;33:503–516
  9. Offenbacher S, Boggess KA, Murtha AP, et al. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol. 2006;107:29–36
  10. Michalowicz BS, Hodges JS, DiAngelis AJ, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med. 2006;355:1925–1927
  11. Hansen AR, Collins MH, Genest D, et al. Very low birthweight infant’s placenta and its relation to pregnancy and fetal characteristics. Pediatr Dev Pathol. 2000;3:419–430
  12. Arias F, Victoria A, Cho K, et al. Placental histology and clinical chatacteristics of patients with preterm premature rupture of membranes. Obstet Gynecol. 1997;89:265–271
  13. Hansen AR, Collins MH, Genest D, et al. Very low birthweight placenta; clustering of morphologic characteristics. Pediatr Dev Pathol. 2000;3:431–438
  14. Arias F, Rodriguez L, Rayne SC, et al. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168:585–591
  15. Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002;99:490–496
  16. Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28:67–80
  17. Salafia CM, Pezzullo JC, Minior VK, et al. Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol. 1997;90:830–836
  18. Viscardi RM, Sun CC. Placental lesion multiplicity: risk factor for IUGR and neonatal cranial ultrasound abnormalities. Early Hum Dev. 2001;62:1–10
  19. Laurini RN, Visser GHA, Ballegooie E, et al. Morphological findings in placentae of insulin-dependent diabetic patients treated with continuous subcutaneous insulin infusion. Placenta. 1987;8:153–165
  20. Ogino S, Redline RW. Villous capillary lesions of the placenta: Distinctions between chorangioma, chorangiomatosis, and chorangiosis. Hum Pathol. 2000;31:945–954
  21. Colwell JA, Jokl R. Vascular thrombosis in diabetes. In:  Porte D,  Sherwin S editor. Ellenberg and Rifkin’s Diabetes Mellitus. (ed 5). Stamford, CT: Appleton Lange; 1997;p. 207–216
  22. Heller DS, Rush D, Baergen RN. Subchorionic hematoma associated with thrombophilia: report of three cases. Pediatr Dev Pathol. 2003;6:261–264
  23. Arias F, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med. 1998;7:277–286
  24. Redline RW. Thrombophilia and placental pathology. Clin Obstet Gynecol. 2006;49:885–894
  25. Shekhawat P, Matern D, Strauss AW. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res. 2005;57:78R–86R
  26. Spiekerkoetter U, Khuchua Z, Bennet MJ, et al. General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha or beta subunit mutations exhibit similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover. Pediatr Res. 2004;55:190–196
  27. den Boer MEJ, Wanders RJA, Morris AAM, et al. Long-chain 3-hydroxyacyl-C0-A dehydrogenase deficiency: clinical presentation and followup of 50 patients. Pediatrics. 2002;109:99–104
  28. Matern D, Shehata BM, Shekhawat P, et al. Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab. 2001;72:265–268
  29. Machin GA. Hydrops revisited: literature review of 1414 cases published in the 1980’s. Am J Med Genet. 1989;34:366–390
  30. Machin GA. Hydrops, cystic hygroma, hydrothorax, pericardial effusions, and fetal ascites. In:  Gilbert-Barness E editors. Potters Pathology of the Fetus and Infant. St. Louis, MO: Mosby; 1997;p. 163–181
  31. Larroche JCI, Aubry MC, Narcy F. Intrauterine brain damage in nonimmune hydrops fetalis. Biol Neonate. 1992;61:273–280

PII: S0740-2570(07)00027-5

doi: 10.1053/j.semdp.2007.02.003

Seminars in Diagnostic Pathology
Volume 24, Issue 1 , Pages 43-47 , February 2007

Article Tools